A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates☆,☆☆,★,★★
Presented in part at The Society for Pediatric Research (SPR), Washington, DC, May 1996.
Under a Creative Commons license
open archive
Abbreviations
ANC
Absolute neutrophil count
PML
Polymorphonuclear leukocyte
rhu GM-CSF
Recombinant human granulocyte-macrophage colony-stimulating factor
VLBWNs
Very low birth weight neonates
Cited by (0)
- ☆
†Deceased.
- ☆☆
Supported by grants from the Pediatric Cancer Research Foundation, the Walden W. and Jean Young Shaw Foundation, and Immunex Corporation. Each Principal Investigator and their respective institutions received grant support from Immunex Corporation for laboratory evaluation and/or data management relative to the conduct of the study.
- ★
Reprint requests: Mitchell S. Cairo, MD, Department of Pediatrics, Georgetown University, Lombardi Cancer Center, 3800 Reservoir Rd NW, 2-E Main Hospital, Washington, DC 20007.
- ★★
0022-3476/99/$8.00 + 09/21/95138
Copyright © 1999 Mosby, Inc. All rights reserved.